Le Lézard
Classified in: Health, Science and technology
Subject: TRI

Applied BioMath, LLC Announces Collaboration with Verseau Therapeutics for System Pharmacology Modeling in Oncology


CONCORD, Mass., Aug. 3, 2020 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their collaboration with Verseau Therapeutics for the development and delivery of a systems pharmacology model that will be used for efficacious dose prediction for the treatment of cancer. 

"We previously collaborated with Applied BioMath to evaluate the therapeutic feasibility of a series of assets," said Dr. Tatiana Novobrantseva, Co-founder and Chief Scientific Officer of Verseau Therapeutics. "We look forward to extending this collaboration to predict an efficacious dose for one of our lead macrophage checkpoint inhibitor programs. The intersections between mathematical models and experimental drug development will yield more translatable experiments and better-informed clinical trials."

Applied BioMath employs a rigorous fit-for-purpose model development process which aims to quantitatively integrate knowledge about therapeutics with an understanding of its mechanism of action in the context of human disease mechanisms. Their approach employs proprietary algorithms and software that were designed specifically for systems pharmacology model development, simulation, and analysis. "The mechanistic nature of our systems modeling is ideal for using available data to evaluate Pharmacokinetic (PK)/Pharmacodynamic (PD) relationships when predicting efficacious dose," said Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath. "This allows project teams to make more informed decisions as they head into IND."

About Applied BioMath

Founded in 2013, Applied BioMath's mission is to revolutionize drug invention. Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Their approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, patients, and the best path forward into and in the clinic. For more information about Applied BioMath and its services, visit www.appliedbiomath.com.

Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Press contact: 
Kristen Zannella 
kristen.zannella@appliedbiomath.com

SOURCE Applied BioMath, LLC


These press releases may also interest you

at 04:05
Technavio has been monitoring the HMI software market and it is poised to grow by $ 14.44 bn during 2020-2024, progressing at a CAGR of over 12% during the forecast period. The report offers an up-to-date analysis regarding the current market...

at 02:55
Wipro Limited , a leading global information technology, consulting and business process services company, today organized the 15th edition of the ?Spirit of Wipro' (SOW) Run globally with thousands of participants across 35 countries, running...

at 02:21
OneConnect Financial Technology Co., Ltd. (OneConnect, NYSE: OCFT), a leading technology-as-a-service platform for financial institutions, won the Platinum Award for Digital Banking at the IFTA FinTech Achievement Awards 2019, in recognition for the...

at 02:12
Cellcom Israel Ltd. (the "Company") announced today that following its previous announcement regarding its indirect controlling shareholder, Discount Investment Corporation Ltd., or DIC, announcement that the debenture holders of IDB Development...

at 02:00
GetLinked's modular system lets customers adopt only what they need as new features have been added When searching for financial software, businesses often peruse systems jam-packed with features they'll never use, forcing them to pay for software...

at 01:38
China's leading high-end, premium electric SUV, the HiPhi X, makes its debut at the 2020 Beijing Auto Show. Designed and built by Human Horizons in Shanghai, the HiPhi X combines cutting-edge technical innovation, sustainable manufacturing and...



News published on 3 august 2020 at 14:06 and distributed by: